[
  {
    "ts": null,
    "headline": "Al Gore's Strategic Moves in Q3 2024: Spotlight on Agilent Technologies with a 2.1% Portfolio Impact",
    "summary": "Insights into Generation Investment Management's Latest 13F Filing",
    "url": "https://finnhub.io/api/news?id=87e7c5fbe27e85adfa45fd88e003ea5451f405e858864ded684f7136598afcfd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731614555,
      "headline": "Al Gore's Strategic Moves in Q3 2024: Spotlight on Agilent Technologies with a 2.1% Portfolio Impact",
      "id": 131357317,
      "image": "https://s.yimg.com/ny/api/res/1.2/mhp3tkYUBVLdhYDTw7kjQg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04NzE-/https://media.zenfs.com/en/us.finance.gurufocus/bcf9f4127d4f43e6734047230dc3a9a5",
      "related": "A",
      "source": "Yahoo",
      "summary": "Insights into Generation Investment Management's Latest 13F Filing",
      "url": "https://finnhub.io/api/news?id=87e7c5fbe27e85adfa45fd88e003ea5451f405e858864ded684f7136598afcfd"
    }
  },
  {
    "ts": null,
    "headline": "Agilent Technologies Inc. stock falls Thursday, underperforms market",
    "summary": "Agilent Technologies Inc. stock falls Thursday, underperforms market",
    "url": "https://finnhub.io/api/news?id=f819eb510a9f75d9e3636f62ba24cb26cfa7d6fec50eb775aa5df18a2ba53a09",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731603480,
      "headline": "Agilent Technologies Inc. stock falls Thursday, underperforms market",
      "id": 131424230,
      "image": "",
      "related": "A",
      "source": "MarketWatch",
      "summary": "Agilent Technologies Inc. stock falls Thursday, underperforms market",
      "url": "https://finnhub.io/api/news?id=f819eb510a9f75d9e3636f62ba24cb26cfa7d6fec50eb775aa5df18a2ba53a09"
    }
  },
  {
    "ts": null,
    "headline": "Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research",
    "summary": "SANTA CLARA, Calif., November 14, 2024--Agilent Technologies Inc. (NYSE: A) announces the new Mito-rOCR Assay Kit. This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all skill levels. With this cost-effective and versatile kit, researchers can easily incorporate functional assessment of relative mitochondrial respiration into their cell physiology and disease pathology studies.",
    "url": "https://finnhub.io/api/news?id=886fab5016e236be440b8a9769f8f5c214a6880b45543831a53e1dcf9c57406f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731589200,
      "headline": "Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research",
      "id": 131354273,
      "image": "https://media.zenfs.com/en/business-wire.com/ea4763bcbf640eadbe772eab8105763d",
      "related": "A",
      "source": "Yahoo",
      "summary": "SANTA CLARA, Calif., November 14, 2024--Agilent Technologies Inc. (NYSE: A) announces the new Mito-rOCR Assay Kit. This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all skill levels. With this cost-effective and versatile kit, researchers can easily incorporate functional assessment of relative mitochondrial respiration into their cell physiology and disease pathology studies.",
      "url": "https://finnhub.io/api/news?id=886fab5016e236be440b8a9769f8f5c214a6880b45543831a53e1dcf9c57406f"
    }
  }
]